BMC Cancer | Home page

BMC Cancer | Home page





BMC Cancer

Featured review: Response biomarkers to tailor cancer drug therapy

Amin & Bathe BMC Cancer 2016 - CC

Response biomarkers represent an attractive, yet under-explored alternative to radiographic tests such as CT and PET that are currently used to evaluate individual response to treatment and inform tailored cancer therapy. Shahil Amin and Frank Bathe review the state of the art on treatment response assessment, and propose a framework for response biomarker discovery.

Read more